Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
09/2010
09/21/2010US7799815 2-methyl-6-[(1R,5S/1S,5R)-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hex-1-yl]quinoline, used to treat drug abuse and dependence, psychological disorders, urogenital disorders or as cognition activators
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/16/2010WO2010103283A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103021A1 Composition comprising pesticide and benzotriazole uv absorbers
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010US20100234617 process for preparation of letrozole and its intermediates
09/16/2010US20100234616 Method for the preparation of rufinamide
09/16/2010US20100234404 P-38 Kinase Inhibitors
09/16/2010US20100234378 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors
09/16/2010US20100234254 Lubricating oil additive, lubricating oil composition containing the same, various low-friction sliding members, rolling bearing, and sliding bearing
09/16/2010CA2754941A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2227453A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
09/15/2010CN101830858A Preparation method of 1H-1,2,4-tolyltriazole-3-methyl formate
09/15/2010CN101830857A Sodalite porous coordination polymer material as well as preparation method and application thereof
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/10/2010WO2010100199A1 Fluconazole carboxylic ester derivatives, synthesis, and use in long acting formulations
09/10/2010WO2010100186A1 Fluconazole carboxylic ester derivatives, synthesis, and use in long acting formulations
09/08/2010EP2226317A1 Aryl (1h-1,2,4-triazol-1-yl) compound, and process for production thereof
09/08/2010EP2226316A1 Copper-catalysed ligation of azides and acetylenes
09/08/2010EP2225231A1 Aminotriazole derivatives as alx agonists
09/08/2010EP1693358B1 Process for producing epoxytriazole compound and intermediate therefor
09/08/2010CN1819998B Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same
09/08/2010CN101827828A 1, 2, 4 -triazole derivatives as serotonergic modulators
09/08/2010CN101824002A Water soluble triazole compound and synthesis method thereof
09/02/2010WO2010098600A2 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222401 Compositions and methods for treating pathologic angiogenesis and vascular permeability
09/02/2010US20100222400 F1F0-ATPase Inhibitors and Related Methods
09/02/2010US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
09/02/2010US20100221176 Methods and compositions for protein labelling
09/02/2010CA2751343A1 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/01/2010EP2224013A1 Methods for the determination of telomerase activity using click chemistry
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP1720546B1 Novel, sustained-action beta-2-agonists and their use as medicaments
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101820759A Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives
09/01/2010CN101817793A S-triazolyl alpha-mercaptoacetanildes as inhibitors of HIV reverse transcriptase
09/01/2010CN101817792A Bistriazolone, bistriadimenol compounds with antimicrobial activity, and salts, synthesis method and uses thereof
09/01/2010CN101817784A Ethylene derivatives and pesticides containing said derivatives
09/01/2010CN101239932B Preparation of 3,5-di(2-cyano-isopropyl)-toluene
08/2010
08/31/2010US7786156 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole)
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010CA2269399C Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers
08/26/2010WO2010094289A1 Allosteric binding compounds
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010US20100216984 Novel chromophoric silyl protecting groups and their use in the chemical synthesis of oligonucleotides
08/26/2010US20100216815 N-substituted oxindoline derivatives as calcium channel blockers
08/25/2010CN101812028A 5-chlorol-2-hydroxyl-3-(4-substituted-1H-1,2,3-triazole) benzoic acid compound as well as preparation method and application thereof
08/25/2010CN101323600B Triadimefon and triadimenol compounds having antimicrobial activity, salts, synthetic methods and uses thereof
08/24/2010US7781471 cannabinoid receptor antagonists, used for treating psychological disorders, neurodegenerative diseases, gastrointerstinal disorders, eating disorders, non-insulin dependent diabetes, drug abuse and dependence, headaches, obesity, sleep disorders and dyslipidemia
08/24/2010US7781463 Enzyme inhibitors
08/24/2010US7781462 1-(3,4,5-trimethoxy-phenyl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; 1-(2-hydroxy-4-methoxy-5-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; inhibits tubulin polymerization in a cell; cancer
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093845A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
08/19/2010WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010WO2010091543A1 Novel hydrazino-cyclobut-3-ene-1, 2-dione derivatives as cxcr2 antagonists
08/19/2010WO2010023685A3 Crystalline form of 2-(2-hydroxy phenyl)benz[e][1,3]oxazin-4-one, process for the same and use for producing 4-(3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl)benzoic acid
08/19/2010US20100210854 Cyclopropenones and the Photochemical Generation of Cyclic Alkynes Therefrom
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/18/2010EP2217577A2 Novel compounds and compositions and methods of use
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808988A Piperidine and piperazine derivatives
08/18/2010CN101805303A Substituted hydroxylamine derivatives with anti-inflammatory activity and preparation method and application thereof
08/18/2010CN101805302A 2-(4-phenyl-3-aryloxy-1,2,4-triazole-5-sulfenyl) acetamide and synthesis and application thereof
08/18/2010CN101805301A Method for preparing chiral flutriafol
08/18/2010CN101805300A Method for preparing chiral hexaconazole
08/18/2010CN101307018B Diethylene triaminepentaacetic acid carboxyl active ester or analogues, method for synthesizing same and use
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776897 such as 3-[1-(5-chloro-2-thienyl)cyclopenty]-5,6,7,8,9,10-hexahydro [1,2,4]triazolo[4,3-a]azocine, having a strong 11 beta -hydroxysteroid dehydrogenase type 1inhibitory activity and exhibiting an excellent blood-glucose level-lowering action, used for the therapy of diabetes and insulin resistance
08/17/2010CA2397734C Water soluble prodrugs of azole compounds
08/12/2010WO2010090094A1 Aromatic amino compound manufacturing method
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/12/2010US20100204280 Cinnamoyl inhibitors of transglutaminase
08/12/2010US20100204206 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
08/12/2010US20100200842 Surface modifying agent, laminated structure and transistor including the same, and method of manufacturing the laminated structure
08/11/2010EP2215065A1 Ccr10 antagonists
08/11/2010EP2215052A1 Desferrioxamine conjugates, derivatives and analogues
08/11/2010EP2215049A1 P2x3, receptor antagonists for treatment of pain
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101798290A Method for synthesizing chiral cyproconazole
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087419A2 Ester compound and use thereof
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197871 Ligands for copper-catalyzed azide-alkyne cycloaddition reactions
08/05/2010US20100197806 Method Involving 1-Benzotriazolyl Carbonate Esters of Polymers
08/05/2010US20100197749 Chemical compounds
08/05/2010US20100197696 Pesticidal heterocyclic dihaloallyl compounds
08/05/2010US20100197644 Chemical Compounds 572
08/04/2010EP2212301A1 An improved process for preparation of letrozole and its intermediates
08/04/2010EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
08/04/2010CN101796034A Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010CN101792438A Method for synthesizing 1-substituted-1,2,3-tolyltriazole
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 178